Effect of mesenchymal stem cell transplantation on brain-derived neurotrophic factor expression in rats with Tourette syndrome

Liu,Xiumei; Wang,Xueming; Li,Aimin; Jiao,Xiaoling

doi:10.3892/etm.2016.3059

Effect of mesenchymal stem cell transplantation on brain-derived neurotrophic factor expression in rats with Tourette syndrome

Authors:
- Xiumei Liu
- Xueming Wang
- Aimin Li
- Xiaoling Jiao
View Affiliations

Affiliations: Department of Pediatrics, Yuhuangding Hospital of Qingdao University, Yantai, Shandong 264000, P.R. China
Published online on: February 9, 2016 https://doi.org/10.3892/etm.2016.3059
Pages: 1211-1216
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the effect of bone marrow mesenchymal stem cell (MSC) transplantation on brain‑derived neurotrophic factor (BDNF) expression in the striatum of Tourette syndrome (TS) rats. In addition, the possible mechanism of MSC transplantation in the treatment of TS was investigated. A total of 72 Wistar rats were randomly allocated into the control (sham surgery) group and the two experimental groups, including the TS+vehicle and TS+MSC. MSCs were co‑cultured with 5‑bromodeoxyuridine for 24 h for labeling prior to grafting. An autoimmune TS rat model was successfully established in the present study. Rat MSCs were cultured and expanded using density gradient centrifugation in vitro, identified by flow cytometry and then transplanted into the striata of the TS+MSC group rats. The mRNA and protein expression levels of BDNF were detected by RT‑qPCR and ELISA, respectively. The results indicated that the stereotypic behavior of TS rats was reduced 7 days after MSC transplantation, while the mRNA and protein BDNF levels in the striatum increased, compared with the sham surgery group (P<0.05). In addition, the BDNF mRNA and protein expression level was lower in the striatum of TS+MSC transplantation, compared with that in TS+vehicle rats. In conclusion, intrastriatal transplantation of MSCs may provide relief from stereotypic TS behavior, since the BDNF level was reduced in TS rats after MSC transplantation.

View Figures

View References

1	Tamara P: Tourette syndrome and other tic disorders of childhood. Handb Clin Neurol. 112:853–856. 2013. View Article : Google Scholar : PubMed/NCBI
2	Cheung MY, Shahed J and Jankovic J: Malignant tourette syndrome. Mov Disord. 22:1743–1750. 2007. View Article : Google Scholar : PubMed/NCBI
3	Lv W, Li WY, Xu XY, Jiang H and Bang OY: Bone marrow mesenchymal stem cells transplantation promotes the release of endogenous erythropoietin after ischemic stroke. Neural Regen Res. 10:1265–1270. 2015. View Article : Google Scholar : PubMed/NCBI
4	Choi HS, Kim HJ, Oh JH, Park HG, Ra JC, Chang KA and Suh YH: Therapeutic potentials of human adipose-derived stem cells on the mouse model of Parkinson's disease. Neurobiol Aging. 36:2885–2892. 2015. View Article : Google Scholar : PubMed/NCBI
5	Liu X, Wang Y, Li D and Ju X: Transplantation of rat neural stem cells reduces stereotypic behaviors in rats after intrastriatal microinfusion of Tourette syndrome sera. Behav Brain Res. 186:84–90. 2008. View Article : Google Scholar : PubMed/NCBI
6	Liu XM, Wang YW and Yi MJ: Effects of human mesenchymal stem cell transplantation in the bilateral corpus striatum in a rat model of Tourette's syndrome. Neural Regen Res. 5:1285–1290. 2010.
7	van Velthoven CT, Braccioli L, Willemen HL, Kavelaars A and Heijnen CJ: Therapeutic potential of genetically modified mesenchymal stem cells after neonatal hypoxic-ischemic brain damage. Mol Ther. 22:645–654. 2014. View Article : Google Scholar : PubMed/NCBI
8	Liu X, Wang X, Li L, Wang H and Jiao X: Influence of mesenchymal stem cell transplantation on stereotypic behavior and dopamine levels in rats with Tourette syndrome. PLoS One. 8:e621982013. View Article : Google Scholar : PubMed/NCBI
9	Chen A, Xiong LJ, Tong Y and Mao M: The neuroprotective roles of BDNF in hypoxic ischemic brain injury. Biomed Rep. 1:167–176. 2013.PubMed/NCBI
10	Hornig M and Lipkin WI: Immune-mediated animal models of Tourette syndrome. Neurosci Biobehav Rev. 37:1120–1138. 2013. View Article : Google Scholar : PubMed/NCBI
11	Singer HS, Loiselle CR, Lee O, Minzer K, Swedo S and Grus FH: Anti-Basal Ganglia Antibodies in PANDAS. Mov Disord. 19:406–415. 2004. View Article : Google Scholar : PubMed/NCBI
12	Macri S, Onori MP, Roessner V and Laviola G: Animal models recapitulating the multifactorial origin of Tourette syndrome. Int Rev Neurobiol. 112:211–237. 2013. View Article : Google Scholar : PubMed/NCBI
13	Taylor JL, Rajbhandari AK, Berridge KC and Aldridge JW: Dopamine receptor modulation of repetitive grooming actions in the rat: Potential relevance for Tourette syndrome. Brain Res. 1322:92–101. 2010. View Article : Google Scholar : PubMed/NCBI
14	Malaty IA and Akbar U: Updates in medical and surgical therapies for Tourette syndrome. Curr Neurol Neurosci Rep. 14:4582014. View Article : Google Scholar : PubMed/NCBI
15	Phinney DG and Isakova IA: Mesenchymal stem cells as cellular vectors for pediatric neurological disorders. Brain Res. 1573:92–107. 2014. View Article : Google Scholar : PubMed/NCBI
16	Zhang F, Wang YY, Liu H, Lu YF, Wu Q, Liu J and Shi JS: Resveratrol produces neurotrophic effects on cultured dopaminergic neurons through prompting astroglial BDNF and GDNF release. Evid Based Complement Alternat Med. 2012:9376052012. View Article : Google Scholar : PubMed/NCBI
17	Kordi-Tamandani DM, Sahranavard R and Torkamanzehi A: DNA methylation and expression profiles of the brain-derived neurotrophic factor (BDNF) and dopamine transporter (DAT1) genes in patients with schizophrenia. Mol Biol Rep. 39:10889–10893. 2012. View Article : Google Scholar : PubMed/NCBI
18	Ferrini F and De Koninck Y: Microglia control neuronal network excitability via BDNF signalling. Neural Plast. 2013:4298152013.PubMed/NCBI
19	Paulsen JS: Cognitive impairment in Huntington disease: Diagnosis and treatment. Curr Neurol Neurosci Rep. 11:474–483. 2011. View Article : Google Scholar : PubMed/NCBI
20	Shimada H, Makizako H, Doi T, Yoshida D, Tsutsumimoto K, Anan Y, Uemura K, Lee S, Park H and Suzuki T: A large, cross-sectional observational study of serum BDNF, cognitive function and mild cognitive impairment in the elderly. Front Aging Neurosci. 6:692014. View Article : Google Scholar : PubMed/NCBI
21	Li Y, Yui D, Luikart BW, McKay RM, Li Y, Rubenstein JL and Parada LF: Conditional ablation of brain-derived neurotrophic factor-TrkB signaling impairs striatal neuron development. Proc Natl Acad Sci USA. 109:15491–15496. 2012. View Article : Google Scholar : PubMed/NCBI
22	Niitsu T, Shirayama Y, Matsuzawa D, Hasegawa T, Kanahara N, Hashimoto T, Shiraishi T, Shiina A, Fukami G, Fujisaki M, et al: Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 35:1836–1840. 2011. View Article : Google Scholar : PubMed/NCBI
23	Mang CS, Campbell KL, Ross CJ and Boyd LA: Promoting neuroplasticity for motor rehabilitation after stroke: Considering the effects of aerobic exercise and genetic variation on brain-derived neurotrophic factor. Phys Ther. 93:1707–1716. 2013. View Article : Google Scholar : PubMed/NCBI
24	Martino D, Chiarotti F, Buttiglione M, Cardona F, Creti R, Nardocci N, Orefici G, Veneselli E and Rizzo R: Italian Tourette Syndrome Study Group: The relationship between group A streptococcal infections and Tourette syndrome: A study on a large service-based cohort. Dev Med Child Neurol. 53:951–957. 2011. View Article : Google Scholar : PubMed/NCBI
25	Yeh TK, Hu CY, Yeh TC, Lin PJ, Wu CH, Lee PL and Chang CY: Association of polymorphisms in BDNF, MTHFR, and genes involved in the dopaminergic pathway with memory in a healthy Chinese population. Brain Cogn. 80:282–289. 2012. View Article : Google Scholar : PubMed/NCBI
26	Binder DK, Croll SD, Gall CM and Scharfman HE: BDNF and epilepsy: Too much of a good thing? Trends Neurosci. 24:47–53. 2001. View Article : Google Scholar : PubMed/NCBI
27	Denys D, de Vries F, Cath D, Figee M, Vulink N, Veltman DJ, van der Doef TF, Boellaard R, Westenberg H, van Balkom A, et al: Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder. Eur Neuropsychopharmacol. 23:1423–1431. 2013. View Article : Google Scholar : PubMed/NCBI
28	Stagg J and Galipeau J: Mechanisms of immune modulation by mesenchymal stromal cells and clinical translation. Curr Mol Med. 13:856–867. 2013. View Article : Google Scholar : PubMed/NCBI
29	Brennen WN, Denmeade SR and Isaacs JT: Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment. Endocr Relat Cancer. 20:R269–R290. 2013. View Article : Google Scholar : PubMed/NCBI